Home Healthcare Pharmaceuticals Biologic Excipients Market

Biologic Excipients Market Size, Share & Trends Analysis Report By Excipient Type (Sugars and Sugar Alcohols, Amino Acids, Surfactants, Cyclodextrins, Inorganic Salts, Other Excipients), By Biologic Type (Monoclonal Antibodies, Vaccines, Cell and Gene Therapies, Recombinant Proteins and Peptides, Other Biologics), By End User (Biopharmaceutical and Biotechnology Companies, CMOs and CDMOs, Academic and Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 26, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Biologic Excipients Market, By Excipient Type 2025-2034 (USD MILLION/ Units)
    1. Sugars and Sugar Alcohols
    2. Amino Acids
    3. Surfactants
    4. Cyclodextrins
    5. Inorganic Salts
    6. Other Excipients
  2. Biologic Excipients Market, By Biologic Type 2025-2034 (USD MILLION/ Units)
    1. Monoclonal Antibodies
    2. Vaccines
    3. Cell and Gene Therapies
    4. Recombinant Proteins and Peptides
    5. Other Biologics
  3. Biologic Excipients Market, By End User 2025-2034 (USD MILLION/ Units)
    1. Biopharmaceutical and Biotechnology Companies
    2. CMOs and CDMOs
    3. Academic and Research Institutes
  4. Regional Biologic Excipients Market
    1. North America
      1. North America Biologic Excipients Market By Excipient Type 2025-2034 (USD MILLION/ Units)
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
      2. North America Biologic Excipients Market By Biologic Type 2025-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Cell and Gene Therapies
        4. Recombinant Proteins and Peptides
        5. Other Biologics
      3. North America Biologic Excipients Market By End User 2025-2034 (USD MILLION/ Units)
        1. Biopharmaceutical and Biotechnology Companies
        2. CMOs and CDMOs
        3. Academic and Research Institutes
      4. U.S.
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      5. Canada
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
    2. Europe
      1. Europe Biologic Excipients Market By Excipient Type 2025-2034 (USD MILLION/ Units)
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
      2. Europe Biologic Excipients Market By Biologic Type 2025-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Cell and Gene Therapies
        4. Recombinant Proteins and Peptides
        5. Other Biologics
      3. Europe Biologic Excipients Market By End User 2025-2034 (USD MILLION/ Units)
        1. Biopharmaceutical and Biotechnology Companies
        2. CMOs and CDMOs
        3. Academic and Research Institutes
      4. U.K.
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      5. Germany
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      6. France
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      7. Spain
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      8. Italy
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      9. Russia
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      10. Nordic
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      11. Benelux
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      12. Rest of Europe
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
    3. APAC
      1. APAC Biologic Excipients Market By Excipient Type 2025-2034 (USD MILLION/ Units)
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
      2. APAC Biologic Excipients Market By Biologic Type 2025-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Cell and Gene Therapies
        4. Recombinant Proteins and Peptides
        5. Other Biologics
      3. APAC Biologic Excipients Market By End User 2025-2034 (USD MILLION/ Units)
        1. Biopharmaceutical and Biotechnology Companies
        2. CMOs and CDMOs
        3. Academic and Research Institutes
      4. China
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      5. Korea
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      6. Japan
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      7. India
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      8. Australia
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      9. Taiwan
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      10. South East Asia
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      11. Rest of Asia-Pacific
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
    4. Middle East and Africa
      1. Middle East and Africa Biologic Excipients Market By Excipient Type 2025-2034 (USD MILLION/ Units)
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
      2. Middle East and Africa Biologic Excipients Market By Biologic Type 2025-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Cell and Gene Therapies
        4. Recombinant Proteins and Peptides
        5. Other Biologics
      3. Middle East and Africa Biologic Excipients Market By End User 2025-2034 (USD MILLION/ Units)
        1. Biopharmaceutical and Biotechnology Companies
        2. CMOs and CDMOs
        3. Academic and Research Institutes
      4. UAE
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      5. Turkey
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      6. Saudi Arabia
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      7. South Africa
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      8. Egypt
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      9. Nigeria
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      10. Rest of MEA
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
    5. LATAM
      1. LATAM Biologic Excipients Market By Excipient Type 2025-2034 (USD MILLION/ Units)
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
      2. LATAM Biologic Excipients Market By Biologic Type 2025-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Cell and Gene Therapies
        4. Recombinant Proteins and Peptides
        5. Other Biologics
      3. LATAM Biologic Excipients Market By End User 2025-2034 (USD MILLION/ Units)
        1. Biopharmaceutical and Biotechnology Companies
        2. CMOs and CDMOs
        3. Academic and Research Institutes
      4. Brazil
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      5. Mexico
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      6. Argentina
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      7. Chile
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      8. Colombia
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
      9. Rest of LATAM
        1. Sugars and Sugar Alcohols
        2. Amino Acids
        3. Surfactants
        4. Cyclodextrins
        5. Inorganic Salts
        6. Other Excipients
        7. Monoclonal Antibodies
        8. Vaccines
        9. Cell and Gene Therapies
        10. Recombinant Proteins and Peptides
        11. Other Biologics
        12. Biopharmaceutical and Biotechnology Companies
        13. CMOs and CDMOs
        14. Academic and Research Institutes
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.